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CHAPTER 1 
Introduction 
 3 
1. Introduction 
 
Veterinarians have frequently to deal with wounds to the skin, subcutis, and 
underlying muscles and in many cases, a second intention healing with 
contraction and epithelialization is required.1-3 The management of the wound 
varies according to wound stage and generally includes irrigation, mechanical, 
and chemical debridement, adherent and non-adherent dressing and a range of 
topical medication.4 Recently, many veterinary studies have been focused on 
wound care, especially on new healing strategy, techniques, and products such as 
the use of advance medical dressing and negative pressure therapy with the goal 
to accelerate the healing process.5-12  
The present study would like to better elucidate the possibility of using Acid 
Hyaluronic-based medications for accelerating the healing process in 
spontaneous open wounds in dog.  
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1.1 The healing of the skin 
 
Wound healing is a dynamic process composed by the sequence of different 
phases: Inflammation, Proliferation (also known as repair), and Maturation – 
that overlap in time.1 
 
- Inflammation 
The blood clot generated after disruption of blood vessels and extravasation of 
blood constituents caused during a tissue injury, not only re-establishes 
haemostasis but also provides a provisional extracellular matrix for cell 
migration.13 The release of vasoactive mediators and chemotactic factors from 
platelets and injured parenchymal cells recruits inflammatory leukocytes to the 
site of injury. The wound area starts to be clean from foreign particles and 
bacteria by infiltrating neutrophils.13 At the same time, macrophages bind to 
specific proteins of the extracellular matrix by their integrin receptors stimulating 
phagocytosis of microorganism.14 In addition the presence of monocyte- and 
macrophage-derived growth factors are almost certainly linked to the initiation 
and propagation of new tissue formation in wounds making possible the 
hypothesis that macrophages have a pivotal role in the transition between 
inflammation and repair.15-16 During this phases the classic sign of inflammation 
such as redness, swelling, heat and pain are well detectable and are the result of 
vasodilatation, fluid escape and obstruction of the local lymphatic vessels. 1 
 
- Proliferation (Repair or remodelling phase) 
During this phase proliferative processes such as angiogenesis, fibroplasia and 
epithelialization occur. The transition from the inflammatory to the proliferation 
phase is marked by the invasion of fibroblast that leave collagen on the wound 
 5 
bed, and by the migration and formation of new endothelial structures. The 
combination of these cells forms the red fleshy granulation tissue that fill the 
wound bed, characterizing this healing phase.17 Re-epithelialization begins within 
hours after injury with epidermal cells at the margin of the wound that undergo 
phenotypic alterations that permit cells movement.13,17 As re-epithelialization 
occurs, a progressive accumulation of new basement membrane material under 
the migrating cells is deposed, starting from the margins and continuing inward.  
Over time, the epidermal cells revert to their normal phenotype and become 
firmly attached to the basal membrane and underlying dermis.17 During the 
repair phase, another process called “contraction” occurs. Wound contraction 
involves a complex and superbly orchestrated interaction of cells, extracellular 
matrix, and cytokines.13,17 In particular the orchestra is guided by a unique 
population of mesenchymal cells called myofibroblasts. These myofibroblasts 
contain varying amount of actin, vimentin and desmin that give to the cells 
contractile ability. During this process the wound have a characteristics stellate 
appearance due to the stretching of the surrounding skin. Contraction will 
continue until the wound edges meet or if the tension of the surrounding skin 
equals or exceed the force of contraction.17 
 
- Maturation 
Even in presence of complete re-epithelialization, a remodeling and 
reorganization of the connective tissue occur and may takes months, even years 
leading to a scar formation. This remodeling is characterized by a reduction in 
collagen content by decreased production and increased degradation. The 
growth in mechanical strength is extremely low and a scar achieve a maximum 
strength of only 70-80% of the original tissue.17  
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1.2 The management of open wound in Veterinary Medicine 
 
Despite in nature many open wounds in wild animals heal without the care of a 
veterinarian; in more serious injuries the delays in early effective management 
could have devastating consequences. The clinician can reduce the likelihood of 
complications and pain while improving the chances of a satisfactory functional 
and cosmetic outcome.1  
The clinician has to understand the normal process of healing and what the 
timeframe should be for normal tissue to achieve granulation, control of sepsis 
and epithelialization.17 Consequently the management of the wound varies 
according to wound stage with the aim to optimize the conditions for wound 
healing.3,4  
 
Pavletic in his book described six basic steps to approach the management of 
open wounds1:  
1. Prevention of further wound contamination; 
2. Debridement of dead and dying tissue; 
3. Removal of foreign debris and contamination; 
4. Provision of adequate wound drainage; 
5. Promotion of a viable vascular bed; 
6. Selection of the appropriate method of closure. 
 
To answer to these 6 steps veterinarian generally performed irrigation, 
mechanical, and chemical debridement, and cover the wound with adherent and 
non-adherent dressing and a range of topical medication.4  
 
1.2.1 Advanced medical dressing in Veterinary Medicine 
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In veterinary medicine, many recent studies have been focused on new healing 
strategy and products with the aim to accelerate the healing rate. In this scenario, 
experimental and clinical studies were performed in animals using advanced 
medical dressing already listed in the management of human open wounds.5-12 
 
Some of them have listed below: 
 
- Honey 
The use of honey for human open wounds was already tested 3000 
years ago, but its role have been just recently re-evaluated from the 
modern medical world.18 Its low Ph, the amount of H2O2 and its 
osmolality give to honey an antimicrobial activity and seem to 
participate to the control of inflammatory cytokines release, fibroblast 
and vascular deposition.19 Many different honey-based dressing are 
available. In veterinary medicine the use of manuka honey was tested 
on experimental open wound in horses. At same time point, the daily 
application of manuka honey led to a decrease in wound size respect to 
non-treated wound.8  
 
- Maggot - therapy  
Maggot-therapy involves the use of disinfected fly larvae directly 
applied on the wound bed. Those larvae have the ability to debride the 
wound from necrotic tissue, reduce bacterial contamination due to the 
antimicrobial activity of their secretory products and enhance the 
formation of healthy granulation tissue.20,21 In human medicine, the 
application of maggot-therapy is reserved as the last line treatment of 
chronic wounds unsuccessfully treated after a long period with others 
advance medical strategy.21 In veterinary medicine the experience about 
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the use of maggot to debride wounds is limited to few case reports and 
small cases-series.22-25 Many, in fact, are the possible disadvantages of 
this therapy such as pain, difficult to built a correct dressing, potential 
iatrogenic ammonia toxicity and excessive bleeding if wound is close to 
major vessels.25  
 
- Aloe Vera 
Aloe Vera is a plant well-known for its anti-inflammatory, anti-
oxidative, anti-microbial and immune system modulation properties. 
Although its large use in human dermatology, experimental studies 
focused on its application for accelerate the healing of open wound led 
to contradictory results.26 In veterinary medicine two studies were 
published but the results are still inconsistent to suggest the application 
of Aloe Vera in infected open wounds in animals.27-28  
 
- Plate l e t - r i ch p lasma and plate l e t  ge l  
The platelet gel (PG) is defined by the Italian Board of Health as 
autologous or heterologous hemocomponent obtained by activation of 
hyper-concentrated platelets pellets with calcium and others activating 
substances ( Ministerial Decree March 3rd, 2005).29 In human medicine 
the application of platelet-rich plasma (PRP) was performed 
successfully in many disorders, from ophthalmology to orthopaedics, 
from oromaxillofacial surgery to cutaneous ulcers.30-34 As in human, 
the interest on clinical application of PG growths also in veterinary 
medicine and many clinical experiences were published confirming the 
positive impressions on healing rate.12,35,36 In particular, the 
randomized controlled clinical trials of Tambella et al. (2014) proved 
the efficacy of PG on chronic, bilateral, decubital ulcers in dogs.12  The 
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exact mechanism of action behind these results is not fully understood. 
An hypothesis is based on the fact that platelet realising numerous 
growth factors (GFs), plays an important role in the remodelling phase 
of healing so the use of this PG and PRP imply an increase of GFs on 
the wound bed. More recently the good result reported in chronic 
wound has been also confirmed in small experimental acute wound in 
beagle dogs.37 As many studies have confirmed the advantages in use 
PRP and PG in many veterinary disorders, as also commercially 
available devices to obtain this products have been released. The study 
of Franklin et al (2015) tests five different commercial systems and 
finds out that the characteristics of the PRP products differed 
considerably, suggesting that clinicians should be aware of the data, or 
lack of them, supporting use of a particular PRP for a specific medical 
disorder.38    
 
- Mesenchymal s t em ce l l  
Stem cells are capable to differentiate into several tissues of the body 
and because of this ability they have been used for the healing of acute 
and chronic wounds. They can originate from various sources such as 
bone marrow, peripheral blood, and umbilical cord.39-42 Autologous or 
allogenic mesenchymal stem cells (MSC) derived from bone marrow 
have demonstrated to enhance wound healing, increase blood vessel 
and granular tissue formation. Taking into consideration the donor site 
morbidity and pain for harvesting bone marrow, in human medicine 
another source such as adipose tissue has been  investigated.43  
In veterinary medicine one study reported the use of allogenic MSCs 
from bone marrow on a canine cutaneous wound model.  MCS-treated 
wound showed a more rapid healing rate than control wounds, and 
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this was hypothesized to be linked to the MCSs promoting re-
epithelialization.44 Another case-report reported the combined use of 
PRP and adipose-derived MSC to improve the healing rate on a large 
traumatic cutaneous wound in a dog.45  
 
- Negat ive  Pressure  Wound Therapy 
This healing strategy involves the use of a device that induce the 
presence of localized negative pressure on the wound surface to 
promote wound contraction, angiogenesis and removal of excess fluid.  
This treatment technique was developed in the 1990s for the 
management of chronic wounds but nowadays has been recommended 
for virtually all kinds of acute and chronic wounds in human 
medicine.46 Since 2005 in veterinary literature case report have been 
published on the use of negative pressure wound therapy (NPWT) in 
horses, dogs, cats and tortoise.47-51 More recently case-control 
experimental studies and large case-series clinical studies in dogs have 
been published.5,11,52,53  The NPWT seems accelerate the deposition of 
a smooth, red and healthy granulation tissue optimizing the wound for 
bed surgical closure or second intention healing.5,11At the same time 
epithelialization seems to be retarded suggesting that little benefits can 
be achieved in continuing NPWT for long period (over 10 days).11 
Using NPWT the bandage can be change every 2-3 days but one of the 
problem encountered is the maintenance of a sub-atmospheric 
pressure under the dressing. Pitt and colleagues (2014) described only 
minor complications in dogs that decreased in frequency while staff 
gained experience in applying dressings and became familiar with the 
machines. Even if some home management experiences, the use of 
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NPWT in veterinary medicine is generally reserved to hospitalized 
patients.5  
 
- Hyaluronic  Acid 
Hyaluronic acid (HA) is a glycosaminoglycan consisted of a basic unit 
of two sugars, glucoronic and N-acetyl-glucosamine, that forms a part 
of the extracellular matrix.54 Many in-vitro and in-vivo studies confirmed 
that HA is closely involved in fibroblast proliferation, enhanced 
formation of granulation tissue and angiogenesis, and even in 
keratinocyte proliferation and migration during wound healing process. 
55-60 These promising results associate with a non-immunogenic 
response and its degradation by natural, non-inflammatory clearance 
mechanisms have led to the development of a range of wound dressing 
containing HA for human medical use.55,61-65 In human medicine the 
role of HA in improving the healing rates, no matter the form in which 
is delivered (gel, film, sponge) is well known for wound ulcers of 
various etiologies, burns and epithelial surgical wounds.64 In veterinary 
medicine, the information about the use of HA as a part of wound 
management is little, and nowadays, the benefit results of this molecule 
application on wound healing as a cross-linked HA-based dressing in 
experimental dog court are still controversial.6,7 The first study was 
published in 2011.6 In this study including cross-linked thiolated 
carboxymethylhyaluronic acid (CMHA-S) based gel and film were 
applied on experimental wounds in rats, dogs and horses. Even if in 
dogs the treated wounds tended to be smaller than control group, only 
in horses this tendency became statistically evident.  The gross 
appearance of the wounds in both species indicated a healthier 
granulation tissue and more epithelialization in treated wounds than 
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control.6 The second study published in 2013 included only beagle 
dogs in which experimental 2x2 cm wounds on the trunk were treated 
with the CMHA-S-based gel.7 Although the hypothesis that CMHA-S 
accelerated the healing rate was rejected, by the end of the study 
CMHA-S-treated wound seems to contract more and, by a subjective 
evaluation, results in a smoother granulation tissue and a less-obvious 
scar respect to control wound.7  These results suggested that in 
veterinary patients additional investigations should be advice to better 
elucidate the effects of HA on open wounds’ healing.  
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1.3 History of the hyaluronic acid in wound management  
 
Karl Meyer and John Palmer in 1934 described a procedure for obtaining of a 
novel glycosaminoglycan from the vitreous humour of bovine eyes.66 This 
substance contained an uronic acid and an aminosugar so was named 
“hyaluronic acid”, and it’s sometimes referred as “hyaluronan” due to the fact 
that it exists in vivo as a polyanion and not in the protonated acid form. 
Subsequently in 1964 this molecule was synthetized in vitro and few years later, 
in 1968, was therapeutically used for the first time on a burn.67-68 
Since its discovery, several studies were focused on the role of HA in the 
organisms. Hyaluronic acid is one of the largest components of the extracellular 
matrix (ECM) and it is conserved throughout all mammals. It is found in high 
concentrations in several soft connective tissue, including skin.55 In fact, HA 
plays a vital role in maintaining tissue integrity, as well as in facilitating adhesion 
and differentiation of cells during inflammation, wound repair, and embryonic 
development.56,57 Particularly in the early stage of wound repair, HA provides a 
temporary structure that facilitates the diffusion of nutritional supplies and helps 
rid the wounds of waste products from cell metabolism.69 In addition, HA is 
subsequently closely involved in keratinocyte proliferation and migration.58 
In the physiological condition, HA is highly hydrophilic, surrounded by a sphere 
of water molecules linked by hydrogen bonds. This role of hydration underlines 
the central role of HA in the skin. Otherwise, the water solubility, the rapid 
resorption and short residence time in tissue of the purified form of HA limited 
its possible therapeutic application.  Taking into consideration these aspects, 
several attempts have been made to modify its molecular structure to obtain a 
more stable solid material without delete the inert and non-inflammatory 
properties of HA.70  This led between 80’s and 90’s to the development of 
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hyaluronan esters from the esterification of free carboxyl groups of glucoranic 
acid present along the molecular chain back-bone.71,72  
Alcohol esterification, generally benzyl alcohol, prevents water ingress and it is 
the usual method of stabilisation. In essence, this cross-links the polymer to a 
variable degree leading to molecules with decrease solubilities. Additionally, 
esterification prevents fibroblast binding, so reducing cellular degradation: the 
75% esterified materials is degraded over 7-14 days, whilst the 95% of the 
product could be present in tissue sections after up to 2 moths.70,73  
The improvement of tissue-engineering techniques in human medicine has taken 
to a new application of HA-based materials that have not only been applied in 
the traditional way where a degradable material may be used on its own, but also 
as a support matrix or as a substrate for the delivery of cultured cells or for 
three-dimensional tissue reconstruction.70, 74-76   
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1.4 Wound bed preparation and TIME principles in human 
medicine 
 
One of the major problems in human medicine is to face with chronic wounds. 
Some wounds do not follow a linear progression through the well-known phase 
of healing and in some point of the process abnormality can occur leading to a 
non-healing wound.77  
Wound bed preparation (WBP) attempted to correct chronic wound 
management with the initial aim of preparing the wound to accept advanced 
wound healing therapies. In fact, it became clear that an advance therapy applied 
on a poorly prepared wound bed could not succeed.  The preparation of the bed 
included attention to viable tissue, control of bacterial burden, control of 
inflammation and moisture balance, and stimulation of the tissue migration from 
the wound edges.77  
From the initial aim, WBP soon evolved into a method that could be used to 
stimulate the endogenous process of wound repair, even without the need of 
advanced therapies. In 2000, Sibbald et al. defined WBP as a “changing 
paradigm that links treatment to the cause and focuses on three components of 
local wound care: debridement, wound-friendly moist interactive dressings and 
bacterial balance”.78 
These three components are a toll for systematically assessing the wound in 
terms of tissue, infection/inflammation and moisture and for carrying out 
interventions based on and understanding of the underlying cellular disruption. 
Otherwise the last aspect of a wound was not considered. In fact, the ultimate 
aim was to close the wound by stimulating the migration of epidermal tissue 
from the wound edges.77  
Adding this fourth component, in 2002 the acronym TIME was released:79 
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- T for tissue: non viable or deficient 
- I for infection/inflammation 
- M for moisture balance 
- E for edges of wound 
 
Wound bed preparation became a cyclical process of wound management where 
assessment was followed by intervention, which in turn was followed by further 
assessment.77  
Although WBP and TIME have focused on correcting abnormalities inside pre-
existing chronic wounds, potentially all acute wounds may become chronic if 
recovery is not optimal, so even acute wounds could benefit from WBS and 
TIME concepts with the aim to not translate them into non-healing wounds.77    
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1.5 The assessment of healing 
 
One of the problems encountered in the evaluation of the healing process is also 
how to evaluate it. The high number of assessment methodologies published in 
human medicine reflects the complexity of objective wound healing assessment 
and the ongoing need for an ideal method.80 Despite no methods was find 
adequate for all wound types,80 appropriate and periodic wound evaluation has 
been shown to be a moderately sensitive and specific way to alert clinicians to a 
less than optimal treatment outcome or a need of re-evaluation of the 
therapeutic strategy in that patient.81,82  In addition monitoring the wound 
healing can help the communications among clinicians by defining a common 
language and standardising assessment of wound characteristics, at least in the 
same medical institution.83  
The end point of the healing process is to obtain the restitutio ad integrum of the 
skin layer, and the progressive reduction of wound area is the mainstay 
parameter to assess. Despite this consideration, a single characteristic can neither 
provide all the necessary data to determine the adequacy of the treatment plan, 
nor allow the progress and the degeneration of the wound.84 In human medicine 
the dimensional assessment is associated with visual and physiological 
evaluations.81 Scale scoring systems, particularly for chronic wounds, were 
available in human medicine. Points are given according to many parameters and 
than a total score is calculated.80,82,85 Wound that shows a plateu in the total score 
in 2 to 4 weeks are generally considered non-progressive and it should be 
revaluated to determine why healing has stopped and if treatment change is 
necessary.82  
In veterinary studies the dimension of the wound surface is the sole parameter 
evaluated to determine the healing progression but recently the addition of other 
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factors such as characteristics of the wound bed and of the periwound tissue 
have been discussed, but not yet evaluated, as other quality parameters for 
verifying the healing process and also the wound care therapy application.7,11 
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CHAPTER 2 
Aim of the study 
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2. Aim 
 
Due to the little information on literature, the aim of this study was to collate a 
sample of canine patient with full-thickness skin wounds healed by second 
intention and to explore on theme the use of available in commerce HA-
containing wound dressing, detailing the difficulties, adverse events, costs, and 
wound outcome. In addition to wound dimensions, the progresses of the 
wounds were also followed using two wounds assessment scales borrowed from 
the human medicine that quantitatively described the status of salient physiologic 
wound characteristics. 
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CHAPTER 3 
Materials and Methods 
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3. Materials and Methods 
 
3.1 Ethical approval 
This study was performed at the Department of Clinical Science and Public 
Health of the University of Milan. It did not include experimental animals and it 
was performed on client-owned dogs referred to our institution for therapeutic 
purpose. All owners gave us the consensus for treatments, measurements and 
for data recording. All clinical procedures were performed in according with 
Italian law (DL 14th march 2014 n.26) and Europe Union legislation covering the 
use of animals for scientific purpose  (“Animal Scientific Procedures 
Act” 63/2010/EU). 
 
3.2 Inclusion Criteria  
Animals prospectively included in the study were client-owned dogs with 
cutaneous open wounds healed completely by only second intention 
consecutively referred from January 2013 to February 2014. All wounds had at 
least a full-thickness skin lost and were treated using available in commerce HA-
containing wound dressing from the date of admission to the date of complete 
re-epithelialization. Due to the absence of specific veterinary formulation in our 
country, HA-based medications available in commerce for human medicine were 
used, and informed owner consent was obtained for each dog. The complete re-
epithelialization was assessed independently by two veterinary surgeons. All 
animals included had to be followed-up at least until complete re-
epithelialization of the wound. Any wound in which was achieved a primary, a 
delayed primary or a secondary closure were excluded from the study.  
All dogs included underwent a physical examination before starting any 
evaluation and treatment of the wound. For patients referred for traumatic 
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injuries any possible reason of life-threatening were excluded or managed before 
starting cutaneous open wound evaluation. 
Other data recorded in the clinical record were: Signalment, weight and body 
condition score (BCS - scoring from 1 to 5)86 , etiology (if known), site of the 
lesion, complete blood sample evaluation (complete blood count, biochemistry), 
any concomitant drugs administration (e.g. corticosteroids, anti-blastic therapy), 
and any concomitant disease (e.g. bone fracture, cavitary collections, metabolic, 
or endocrinologic disease). If referring veterinarian had already treated a wound 
before referred it, type of treatment and timing of treatment were recorded. 
 
3.3 Wound Assessment Methods 
The wound area was calculated using two methods. First, each wound has been 
approximated to a rectangular figure, and the area was calculated multiply the 
two maximum perpendicular diameters measured in a bi-dimensional 
representation. The two measures were achieved using a digital caliper or in 
presence of wound above the curves of the body whit a soft meter and the limits 
for the evaluation of the diameters were the macroscopic margins of epithelial 
tissue. Secondary, a digital photograph of the wound was obtained at each 
clinical control and uploaded in a wound tracing software program (NIH ImageJ 
software, http://rsb.info.nih.gov/nih-image/) that calculated the wound area. 
For both methods, wound area was interpreted as 100% on admission and the 
areas on subsequent controls were expressed as a percentage of admission value 
using the formula: 
At/A0*100 
Where, A0 is the area on admission and At is the wound area on control date. 
 
All wounds included in the study were also prospectively classified at admission 
and during healing process by means of two scale scoring systems, Bates-Jensen 
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Wound Assessment Tool (BWAT) and wound bed scoring (WBS).85, 87-90 The 
BWAT includes 4 parameters scoring from 0 to 5 (size, depth, edges, 
undermining) and 9 parameters scoring from 1 to 5 (necrotic tissue - type and 
amount, exudate - type and amount, surrounding skin color, peripheral tissue - 
edema and induration, granulation tissue, epithelialization). The wound 
assessment results by adding the score of each parameter from a minimum of 9 
(the best score) to a maximum of 65 (the worst score (Figure 1).85,87-89 The WBS 
comprised an evaluation of 8 parameters (black eschar - eczema/dermatitis - 
depth - scarring - color of wound bed - edema/swelling - resurfacing epithelium 
- exudate amount) scoring from 0 to 2. Using this scale a wound could range 
from a maximum of 16 (the best score) to a minimum of 0 (the worst score) 
(Figure 2).90 In both scales in the presence of multiple features of the same 
parameter the worst score was reported. Two surgeons independently performed 
the assessments. The quality and type of exudate were evaluated on the basis of 
how the removed bandage looked like while all other parameters were assessed 
after irrigation (with saline) by means of 20 ml syringe and a gentle sterile gauze 
sponges handing with the purpose to remove the superficial biofilm. 
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Figure. 1 Bates-Jensen Wound Assessment Tool (BWAT) 
Item  Assessment  
Size  
(length x width) 
0. Healed, resolved wound 
1. < 4 cm2 
2. 4-16 cm2 
3. 16.1 < 36 cm2 
4. 36.1 < 80 cm2 
5. > 80 cm2 
Depth 
 
0. Healed, resolved wound 
1. Non-blanchable erythema on intact skin 
2. Partial thickness skin loss involving epidermis and/or 
dermis 
3. Full thickness skin loss involving damage or necrosis of 
subcoutaneous tissue; may extend down to but not 
through underlying fascia; and/or mixed partial and full 
thickness and or tissue layers obscured by granulation 
tissue 
4. tissue layers obscured by necrosis 
5. Full thickness skin loss with extensive destruction, tissue 
necrosis or damage to muscle, bone or supporting 
structures 
Edges 0. Healed, resolved wound 
1. Indistinct, diffuse, none clearly visible 
2. Distinct, outline clearly visible, attached, even with 
wound base 
3. Well-defines, not attached to wound base 
4. Well-defined, not attached to base, rolled under, 
thickened 
5. Well-defines, fibrotic, scarred or hyperkeratotic 
Undermining 0. Healed, resolved wound 
1. None present 
2. < 2 cm in any area 
3. 2-4 cm involving < 50% wound margins 
4. 2-4 cm involving > 50% wound area 
5. > 4 cm or tunnelling in any area 
5. Necrotic tissue type 1. None visible 
2. White/grey non viable tissue and/or non-adherent 
yellow slough 
3. Loosely adherent yellow slough 
4. Adherent, soft, black eschar 
5. Firmly adherent, hard, black eschar 
6. Necrotic tissue 
amount 
1. None visible 
2. <25% of wound bed covered 
3. >25-50% of wound bed covered 
4. >50-75% of wound bed covered 
5. >75-100% of wound bed covered 
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7. Exudate type 1. None 
2. Bloody 
3. Serosanguineous: thin, watery, pale red/pink 
4. Serous: thin, watery, clear 
5. Purulent: thin or thick, opaque, tan/yellow, with or 
without odor  
8. Exudate amount 1. None, dry wound 
2. Scant, wound moist but no observable exudate 
3. Small 
4. Moderate 
5. Large 
9. Skin colour 
surrounding wound 
1. Pink or normal for ethnic group 
2. Bright red and/or blanches to touch 
3. White or grey pallor or hypopigmented 
4. Dark red or purple and/or non-blanchable 
5. Black or hyperpigmented 
10. Peripheral tissue 
edema 
1. No swelling or edema 
2. Non-pitting edema extends < 4 cm around wound 
3. Non-pitting edema extends > 4 cm around wound 
4. Pitting edema extends < 4 cm around wounds 
5. Crepitus and/or pitting edema extends > 4 cm around 
wound  
11. Peripheral tissue 
induration 
1. None present 
2. Induration, < 2 cm around wound 
3. Induration 2-4 cm extending < 50% around wound 
4. Induration 2-4 cm extending > 50%around wound 
5. Induration > 4 cm in any area around wound 
12. Granulation tissue 1. Skin intact or partial thickness wound 
2. Bright, beefy red; 75 to 100% of wound filled and/or 
tissue overgrowth 
3. Bright, beefy red; < 75 to >25% of wound filled 
4. Pink and/or dull, dusky red and/or fills  25% or less of 
wound 
5. No granulation tissue present 
13. Epithelialization  1. 100% wound covered, surface intact 
2. 75-100% wound covered and/or epithelial tissue extends 
>0.5 cm into wound bed 
3. 50-75% wound covered and/or epithelial tissue extends 
to < 0.5 cm into wound bed 
4. 25-50% wound covered 
5. <25% wound covered 
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Figure 2.  Wound bed scoring (WBS) 
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3.4 Wound management protocol  
Because wound healing is a dynamic process, all wounds were prospectively 
managed with HA-containing dressing based on TIME principles [35] in 
according to the characteristics of the open wound and also to manufacture’s 
instruction. In presence of necrotic tissue (BWAT amount of necrotic tissue 
score ≥2 and/or WBS black Eschar score ≤1) a debridement (surgical sharp 
debridement [SD] and/or medical debridement [MD]) were always applied. The 
MD consisted of HA plus collagenase-based topical enzymatic debridement 
agent (Bionect Start®, Fidia Farmaceutici S.p.A., Abano Terme - PD, Italy) or a 
HA plus sodium alginate sterile micro-granules medication (Hyalogran®, Fidia 
Farmaceutici S.p.A., Abano Terme - PD, Italy). In absence of macroscopic 
necrotic tissue (BWAT amount of necrotic tissue score = 1 and WBS black 
eschar score = 0) an adsorbent medication made of partial benzyl ester 
derivative of hyaluronan (Hyalofill-F®, Fidia Farmaceutici S.p.A., Abano Terme - 
PD, Italy) was used when granulation tissue was forming or, when wound did 
not include deep tissue damage, a daily application of a spray composed by HA 
plus silver (Hyalosilver®, Fidia Farmaceutici S.p.A., Abano Terme - PD, Italy) 
was applied. When the open wound was entirely filled by granulation tissue 
(BWAT granulation tissue score = 2 and WBS color of wound bed = 2) the 
owners were instructed to daily apply a HA based topical medication 
(Connettivina®, Fidia Farmaceutici S.p.A., Abano Terme - PD, Italy) until 
complete epithelialization. If different and simultaneous features characterized 
different part of the wound a mix of this product was used. In all cases, the 
second layer of the bandage was composed by cotton padding and then a third 
layer of the latex-coated cohesive bandage (Easifix Cohesive®, BSN medical, 
Vibraye, France) was applied. A tie-over bandages was used to fix the second 
layer in area difficult to cover (e.g. inguinal area). 
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First wound area and assessments evaluation were performed the date of the 
first clinical examination for traumatic and primary closure complication wounds 
(CW), or the date of surgery for excision wounds. After, the assessments and 
wound area measurement were repeated at every bandage change performed by 
clinicians. All the bandage changes were sterilely performed. If needed or require 
by the owner adjunctive control respect to the clinical examination scheduled 
were performed, and the cause of earlier evaluation was recorded. Numbers and 
frequency of wound assessment for each animal were also reported. In the case 
of surgical SD all the assessments, including wound area measurements, were 
performed both before and after to evaluate the impact of the surgical 
procedure. When owners applied the HA-medications at home, a weekly clinical 
examination to assess the wound progress was scheduled. During each clinical 
examination, owners were asked to inform of any difficulties or disadvantage 
retrieved with the bandage. The presence of complete wound healing was 
assessed by the evaluation of the clinician and corresponded to a wound covered 
entirely by epithelial tissue in the absence of any sign of granulation tissue. Time 
of complete wound healing (TWH) was recorded and defines as the time from 
first assessment to complete re-epithelialization (100% of the wound area).  
When complete re-epithelialization was assessed cosmetic and functional 
outcome were also evaluated and recorded in the clinical record.  
During the study period, the use of antibiotic therapy was recorded. The use of 
antibiotics was reserved to wounds showed sign indicative of infection such as: 
Severe soft tissue swelling, erythema, pain, hyperthermia and/or purulent 
discharge. The antibiotics were chosen on the basis of anti-biogram results if a 
swab sample or a biopsy of the wound bed for microbiological culture was 
available. The antibiotic administration was stopped when the signs of infection 
were completely regressed, and a healthy granulation tissue (BWAT granulation 
tissue score = 2 and WBS color of wound bed = 2) was forming.  
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When the animals underwent general anesthesia, anesthetic protocol consisted of 
a multimodal approach including analgesic therapy. The protocol differed among 
animals, and it was calibrated on the basis of the clinical examination of the 
single animal and the type of procedure that had to be performed (surgical SD 
vs. bandage change). In all cases after surgical debridement and in every case in 
which pain was detected an analgesic therapy consisted of non-steroidal anti-
inflammatory drug oral administration was prescribed to obtain pain relief. 
 
3.5 Statistical Analysis 
Pattern of wound area reduction (both methods) during follow-up was evaluated 
by analysis of variance model (ANOVA) for repeated measures. As a pre-fixed 
schedule for clinical examination was not planned and follow-up time was 
heterogeneous, 4 times which were common for all subjects were considered: 7, 
14, 21, 28 days. To account for the correlation of the measures within the same 
subject, a variable identifying subject was considered in the ANOVA model as 
random effect, whereas days was included as fixed effect by dummy variables 
(mixed model ANOVA). To compare the pattern of the WBS and BWAT with 
the pattern of wound area reduction the first two scales were transformed as 
percentages of scoring as follows. For BWAT, the score at time 0 was 
considered as 100%. The maximum reduction for the patient was the difference 
between the initial score and the best achieved score (MR BWAT: BWAT at 
time 0-9). For each time, the difference between the initial score and observed 
score was calculated (difference BWAT). The percentage was then obtained as: 
100-(diff BWAT/MR BWAT)*100 
For WBS, the score at time 0 was considered as 100%. The maximum increase 
for the patient was the difference between the best score achieved and the initial 
score (MI WBS: 16-WBS at time 0). For each time, the difference between the 
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observed score and the initial score was calculated (difference WBS). The 
percentage was then obtained as: 
100-(diff WBS/MI WBS)*100 
The pattern of the transformed scales was then analyzed by mixed model 
ANOVA. The probability of reaching 0% (the best achieved score) during time 
for wound area reduction, BWAT, and WBS scores was estimated by Kaplan–
Meier method. This method allowed to estimate the median time to complete 
wound area reduction (and the best achieved score of BWAT and WBS). Due to 
the low number of patients and preliminary aim of this study no formal 
statistical test on ANOVA were performed. Results are reported as model 
estimated reduction and 95% confidence intervals (CI). No adjustment was 
performed by covariate effects.  
The agreement between the BWAT and WBS scoring independently attributed 
to the patients by two veterinary surgeons was evaluated by the intraclass 
correlation coefficient (ICC) based on two-way repeated ANOVA model with 
random effects. 
As two methods were used to evaluate wound area (the approximation to a 
rectangular and software), an explorative comparison was performed on all the 
available wound measurements. No one of the two methods could be 
considered as gold standard thus the “exact” wound area was approximate by 
the average of the two calculated areas. The comparison was then examined by 
plotting the differences between the two areas measures against their average, as 
suggested in the Bland and Altman plot. Since the aim was only explorative no 
limits of agreement were calculated but, following a practical perspective, the 
percentages of measurements differences within defined ranges were reported. 
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4. Results 
 
4.1 Population 
Twelve open wounds in ten dogs were enrolled in the study. Breeds were as 
follows: Mixed-breed (2), Jack Russel Terrier (2), Dogue de Bordeaux (1), Irish 
Wolfhound (1), Dogo Argentino (1), Whippet (1), Pinscher (1) and American Pit 
Bull Terrier (1). Four dogs were females (1 neutered) and 6 were males (2 
neutered). At admission, mean age was 7.9 years (range 1-15 years) and mean 
body weight was 23.1 kg (range 5-47 kg). Two dogs had a BCS of 2, in 5 dogs 
the BCS was 3 and in the last 2 dogs was 4. 
At admission, three dogs reported comorbidities related to past history: 
Cardiopathy (2) and diabetes mellitus (1). Two dogs reported in the recent 
clinical history (2 weeks or less before admission) one or more surgical malignant 
tumor excision in location not associated to the wound: Perivascular wall tumor 
(1), mast cell tumor (1) and femoral osteosarcoma (1). One dog was surgically 
treated for a foreign body abscess of the mandibular region 2 weeks before 
admission. 
The hematological parameters at admission were unremarkable in all but two 
dogs in which hypoalbuminemia (1) and high glucose level (1, the dog with 
diabetes mellitus) were found. 
 
4.2. Wound data 
A total of 12 wounds were included (2 dogs had 2 simultaneous and 
anatomically split wounds) and treated with HA-based medications until 
complete re-epithelialization. All wounds were summarized in Table-1. The 
wounds were classified on the basis of the etiology in: Traumatic wounds (TW, 
7), primary closure complication wounds (CW, 2) or excised wounds (EW, 3) in 
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presence of skin defect intentionally leaved by surgeon. The specific nature of 
trauma was reported in Table-1. Two TW were referred in presence of unhealthy 
and deteriorating wound appearance after 10 days of previously treatments: 
Surgical apposition of traumatized cutaneous margins (Table-1) and naftalina 
granules and saline solution irrigation (Table-1). Regarding wounds developed 
after malignant tumor excision, the histologic margins were infiltrated in two 
cases (Table-1). No one wounds presented healthy granulation tissue at time to 
admission. 
At admission, the median wound area using the approximation to a rectangular 
figure was 32 cm2 (min 5.40, max 561). In all cases were debridement (SD 
and/or MD) was applied the wound areas had an average increase of 14.4 cm2 
(Table-2). 
At admission, the median wound area using the software was 22 cm2 (min 2.67, 
max 417.29). In all cases were debridement (SD and/or MD) was applied the 
wound areas had an average increase of 10.19 cm2 (Table-2). 
At admission, the median BWAT score was 32.5, while for WBS was 11. In the 7 
wounds in which debridement had been applied, the median BWAT score 
improved from 38 to 32, corresponding to a median decrease from admission 
score of 6, while the median WBS score improved from 8 to 11, corresponding 
to a median increase from admission WBS score of 2 (Table-2). 
All dogs were discharged at home the day of admission and returned to the clinic 
only for dressing changes and clinical controls. The median numbers of return to 
the clinic for bandage change (excluding the date of admission) was 5 times, 
(range, 4-14 times). When dressing was applied by the owner wounds were 
generally rechecked once a week (median, 7 days; range, 2-16 days). When the 
adsorbent medication made of partial benzyl ester derivative of hyaluronan was 
applied, the dressing was always revised by the clinician, and bandages were 
generally changed every 4 days (median, 4 days; range, 2-7 days). In the 2 widest 
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TW (Table-1 and Figures-10 and -11) due to the amount of exudate a silver-pad 
foam (Cellosorb Silver®, Laboratoires URGO, ChenO, Cedex, France) was 
applied over the HA-based medication before the second layer of the bandage 
until scoring for the amount of exudate achieved 2 out of 5 for BWAT and 2 out 
2 for WBS. Due to the location and the size of the wounds a tie-over bandage 
was applied in both cases. 
In 5 wounds (3 dogs) antibiotic therapy was administered. In wounds 3, 4, 5 
(Table-1) a swab test was performed due to the presence of purulent discharged 
and peripheral tissue erythema. In these cases Klebsiella pneumoniae was retrieved 
and an antibiotic protocol with marbofloxacin was started as anti-biogram results 
suggested. In wounds 6 and 7, the dog had been already under enrofloxacin 
administration before the admission, and the protocol was continued until 
appearance of granulation tissue due to the nature of the lesion even if no 
particular signs of infection were presented at that moment.  
Excluding the SD that was always performed under general anesthesia, only for 
the management of wound 4 (Table-1) sedation was performed at every bandage 
change (every 3 days) until day 10 from admission. This was the widest wound 
and for clinical control the dorsal recumbency was necessary creating particular 
discomfort for the dog during this initial period. All other bandage changes in 
this dog and all bandage changes in the other patients were performed with 
wakeful dogs.  
All the products were well tolerated by dogs, and no side effect was retrieved. 
Only one dog was prone to removing the bandage, and earlier returns to the 
clinic than scheduled were necessary also because the owner did not follow the 
suggestion to use Elizabethan collar (Table-1). Some owners complained the 
presence of an unpleasant odor of the bandage. This was correlated to high 
amount of exudate and breaks down of the HA-based products but not to 
infection as also assessed by the improvement of the wound status. When spray 
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formulation was used, owners reported that some dogs felt a little uncomfortable 
sensation due to the noise. The cosmetic result was considered good even if in 
all cases an alopecia area of different dimension has been retrieved. In addition, 
the skin in this area looks thinner and in some cases hyper-pigmented but no 
complication was reported related to these condition. No range motion 
alteration due to contracture were observed even for wounds located close to 
flank, axillar or other joint, and the functional outcome was judged great in all 
dogs. 
 
4.3 Outcome 
The median TWH was 34 days. The 0.25, 0.50, and 0.75 cumulative probability 
to be healed in this study was reached at 21, 34, and 54 days, respectively 
(Figure-3). No wounds were considered healed at 14 days, 3 were considered 
healed within 21 days (cumulative probability of healing: 0.25; 95% CI: 0-0.46), 5 
wounds within 28 days (cumulative probability of healing: 0.42; 95% CI: 0.06-
0.64), 7 wounds within 35 days (cumulative probability of healing 0.58; 95% CI: 
0.19-0.79), and 10 wounds within 63 days (cumulative probability of healing 
0.83; 95% CI: 0.41-0.95) (Table-1). 
In all wounds the best BWAT score was achieved at the same date when 
clinician assessed the complete healing. Eleven out of 12 wounds achieved the 
minimum BWAT score of 9 while 1 wound achieved the score of 10. The 
pattern of cumulative probability to achieve the best BWAT score was 
superimposable to that previously reported for wound area reduction (Figure-3). 
Considering the WBS scale, the 0.25, 0.50, and 0.75 cumulative probability to 
achieve the best WBS score was reached at 9, 14, and 35 days, respectively 
(Figure-3). Two wounds reached the best WBS score within 7 days (cumulative 
probability 0.17; 95% CI: 0.00-0.35), 6 wounds reached the best WBS score 
within 14 days (cumulative probability 0.50; 95% CI: 0.12-0.72), 7 wounds 
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reached the best WBS score within 21 days (cumulative probability 0.58; 95% 
CI: 0.19-0.79) and no wound further reached the best WBS score between 21 
and 28 days. In all cases, the best score was reconfirm in the subsequent 
assessments until complete epithelialization was achieved. 
Considering the 1st month of treatment, the weekly mean percentages of two-
axis wound area, software wound area, BWAT and WBS scores respect to 
admission values are illustrated in Figures 4-5-6-7, respectively. 
When another clinician applied both scoring systems, the agreement between the 
two operators was considered good with an ICC of 0.88 for WBS (95% CI: 0.83-
0.91) and of 0.95 for BWAT (95% CI: 0.93-0.97). 
Regarding the comparison between area measurement with rectangular and 
software method, overall 107 measurements were performed with both the 
methods. Since 12 measurements for both method reported 0% at the time of 
complete healing, only the other 95 remaining measures were considered. As the 
differences between methods were related to the area, to facilitate the 
comparison data were subdivided according to the following categories: Areas 
<10 cm2 (28.4% of the data), areas between 10 and 25 cm2 (29.5% of the data), 
areas between 25 and 50 cm2 (17.9% of the data), areas between 50 and 100 cm2 
(11.6% of the data) and areas beyond 100 cm2 (12.6% of the data). 
Measurements with rectangular approximation tend to be greater than 
measurements with software and the differences between the two measurements 
tends to increase with the increasing of the area (Figure-8).  
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Table 1. Wounds included in the study 
Case Weight 
(kg) 
[BCS] 
Age 
(years) 
Type Cause Site Area 
(cm2) 
TWH 
(days) 
Concomi
tant 
drugs 
1 38[4] 5 TW laceration 
(unknown 
origin) 
elbow 18 24 - 
2 15[2] 1 TW hot water pad 
burn 
medial 
thigh 
9.6 21 - 
3 35[3] 4 TW laceration 
(unknown 
origin) 
distal 
forearm 
36 62 - 
4 21.7[4] 6 TW car accident 
(degloving 
injuries) 
ventral 
abdomen 
540 75 - 
5 21.7[4] 6 TW car accident 
(shear injuries) 
lombar 
region 
38.7 35 - 
6 9[4] 8 TW electric pad 
burn 
flank 109,
6 
54 - 
7 9[4] 8 TW electric pad 
burn 
scapular 22,5 17 - 
8 45[3] 4 EW Malignant skin 
neoplasia  
excision 
lateral 
hock 
36 49 vinblastin 
+ 
corticoste
roid 
9 5[3] 14 EW Malignant skin 
neoplasia  
excision 
proximal 
medial 
forearm 
15.1 28 ACE-
inhibitor 
+ 
furosemi
de 
10 6[3] 15 EW Malignant skin 
neoplasia  
excision 
caudal 
thigh 
5,4 34 ACE-
inhibitor 
+ 
furosemi
de 
11 47[3] 11 CW Malignant skin 
neoplasia  
excision 
lateral 
thorax 
32 88 - 
12 9.2[2] 11 CW forelimb 
amputation for 
malignant skin 
neoplasia   
shoulder 10.4 21 Insulin 
 
 
Legend 
TW: traumatic wound, EW= excisional wound, CW: primary closure complication wound.  
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Table 2. Wounds received debridement. 
case 
T
ype of debridem
ent 
T
w
o-axis A
rea (cm
2) 
at adm
ission 
T
w
o-axis A
rea (cm
2) 
post-debridem
ent 
Softw
are A
rea (cm
2)  
at adm
ission 
Softw
are A
rea (cm
2) Post- 
debridm
ent 
B
W
A
T
 
at adm
ission 
B
W
A
T
 
post-debridem
ent 
W
B
S 
at adm
ission 
W
B
S 
post-debridem
ent 
2 MD 9.6 19.2 2.67 8.74 33 28 7 12 
3 SD 36 51.5 30.43 45.47 46 36 4 6 
4 SD 540 561 401.65 417.29 55 45 3 9 
5 MD 38.7 58.8 22.24 54.36 32 27 8 11 
6 SD 109.6 139.5 4.8 5.43 38 32 11 12 
7 SD 22.5 27.3 91.18 91.83 34 24 12 14 
12 SD 10.4 11.2 17.83 18.99 38 34 10 11 
 
Legend 
MD=medical debridement, SD= surgical debridement. The assessment for wound underwent only 
medical debridement referred to day 4 when both the wounds achieved the widest area, for wound 
underwent surgical debridement referred to day 0 (when the surgery was performed).  
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Table 3. Comparison between “two-axis” and “software” methods for measuring the wound 
area.   
 
 Two-
axis 
Wound 
area 
< 9 cm2 
Two-axis 
Wound 
area 
> 9 cm2 and 
< 25 cm2 
Two-axis 
Wound 
area 
> 25 cm2 
and < 50 
cm2 
Two-axis 
Wound 
area 
> 50 cm2 
and < 100 
cm2 
Two-axis 
Wound 
area 
> 100 
cm2 
Total number of 
measurements 
24 31 17 11 12 
Difference 
between the two 
methods 
     
< 1 cm2 12 
(50%) 
5 (16%) - - - 
≥ 1 cm2 and < 2 
cm2 
6 (25%) 1 (3%) 2 (11.8%) 1 (9.1%) - 
≥ 2 cm2 and < 3 
cm2 
6 (25%) 3 (9.7%) 3 (17.6%) - - 
≥ 3 cm2 and < 4 
cm2 
- 2 (6.5%) - - 1 (8.4%) 
≥ 4 cm2 and < 5 
cm2 
- 4 (12.9%) 1 (5.9%) 2 (18.2%) - 
≥ 5 cm2 - 16 (5.6%) 11 
(64.7%) 
8 (72.7%) 11 
(91.6%) 
 
 
Legend.  
Difference greater than 1 cm2 were found in 50%, 84%, and 100% of the areas within 10 cm2, between 
10 and 25 cm2 and greater than 25 cm2 respectively. Differences greater tnan 2 cm2 were found in 
25%m 81%, 88%, 91% and 100% of the areas within 10 cm2, between 10 and 25 cm2, between 50 and 
100 cm2 and greater than 100 cm2, respectively. Differences greater than 5 cm2 were found in 52%, 
65%, 73% and 92% of the areas between 10 and 25 cm2, between 25 and 50 cm2, between 50 and 100 
cm2 and greatern than 100 cm2, respectively.          
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Figure 3. Cumulative probability to be healed considering complete wound area reduction and to reach 
the best BWAT and WBS scores during time.  
 
Figure 4. Mean percentage of “two-axis” wound area respect to T0 during the first month of 
treatment. The mean percentage of wound area at day 7 was 90.41% (95% CI: 77.38 - 103.4), at day 14 
was 47.74% (95% CI: 34.72-60.8), at day 21 was 22.38% (95% CI: 9.36 - 35.4) and at day 28 was 
14.81% (95% CI: 1.78-27.8) of the original size. 
 
 
 
 42 
Figure 5. Mean percentage of software wound area respect to T0 during the first month of treatment. 
The mean percentage of wound area at day 7 was 95.5% (95% CI: 77.33 – 113.8), at day 14 was 54.4% 
(95% CI: 36.22-72.6), at day 21 was 23.10% (95% CI: 4.89 – 41.3) and at day 28 was 14.79% (95% CI: 
-3.42-33) of the original size. 
 
 
Figure 6. Mean percentage of initial BWAT score during the first month of treatment. The mean 
percentage of BWAT score at day 7 was 66.15% (95% CI: 54.7-77.6), at day 14 was 51.96% (95% CI: 
40.5-63.4), at day 21 was 32.63% (95% CI: 21.1-44.1) and at day 28 was 21.70% (95% CI: 10.2-33.2) of 
the admission score.  
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Figure 7. Mean percentage of initial WBS score during the first month of treatment. The mean 
percentage of WBS score at day 7 was 47.71% (95% CI: 27.86-59.6), at day 14 was 22.38% (95% CI: 
6.52-38.2), at day 21 was 14.38% (95% CI: 0-30.2) and at day 28 was 11.43% (95% CI: 0-27.3) of the 
admission score.  
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Figure 8. Comparison of area measurement between two-axis and software methods. Panel a: overall 
wound area measures; panel b: two-axis wound area measures < 10 cm2; panel c: two-axis wound area 
measures >= 10 cm2 and < 25 cm2 ; panel d: two-axis wound area measures >= 25 cm2 and < 50 
cm2; panel e: two-axis wound area measures >= 50 cm2 and < 100 cm2; panel f: two-axis wound area 
measures >= 100 cm2. An increasing trend for the discrepancy between the two methods  whith the 
increasing of the wound area is shown. 
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WOUND CASE-LOG 
Case 3: Traumatic wound on the distal aspect of the forearm. 
 
Fig. 9: A. Wound at time of presentation (T0) after 10 days from the date of the trauma.  
B. The same wound after removing of the suture, trichotomy and irrigation.  
 
 
 
Fig. 9: C. Wound at time of presentation (T0) after surgical sharp debridement.  
D. Wound a week later (T8). Granulation tissue began to form. The gauze with partial benzyl ester 
derivative of hyaluronan were applied.  
A B 
C D 
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Fig.9: E. Wound at 23 days after surgical sharp debridement. The wound bed was entirely filled by red 
granulation tissue. The owner was instructed to daily apply the topical medication. 
F. Wound completely healed (T62). 
  
 
 
Fig. 9: G. Wound healing assessment for case 3. Wound two-axis area: blue line; BWAT assessment: 
red line; WBS assessment: green line.  
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Case 4: Traumatic wound. Ten days before the dog was run down a truck. 
 
 
Fig. 10: A. Wound at time of admission (T0). The wound was previously treated for ten days with 
naftalina granules and saline solution irrigation. The dog was hypoalbuminemic at admission. After 
stabilization of the patient, a surgical sharp debridement was performed.   
 
 
 
Fig.10 : B. Wound a week after admission (T7). A tie-over bandage was applied to fix the medication in 
contact with the wound bed. A granulation tissue began to form and the wound edges created by the 
surgeon during the surgical sharp debridement began to adherent to the underlying tissue. The gauze 
with partial benzyl ester derivative of hyaluronan were used to fill pocket in the inguinal area.  
 
 
 
 
 
 
 48 
 
 
Fig.10: C. Wound at days 40 (T40). The wound area was decreased. The owners were instructed to 
daily apply the topical medication. The wound presented a stellate appearance created by the 
contraction.  The wound was considered completely healed 75 days after admission. 
 
 
  
Fig.10: D. Wound healing assessment for case 4. Wound two-axis area: blue line; BWAT assessment: 
red line; WBS assessment: green line 
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Case 6 and 7: Traumatic burn wounds generated by electric pad during 
anesthesia for malignant tumors excision. 
 
 
Fig. 11: A. Wounds at time of presentation (T0) 14 days after surgical procedure. The hair on the right 
part of the body of the dog was clipped. A topical daily application of hyaluronic acid plus collagenase-
based medication was started to obtain a medical enzymatic debridement. 
 
 
Fig. 11 B.  Wounds after 5 days from the admission. A maturation of the necrotic tissue from a black, 
dry, adherent eschar to a yellow, non-adherent viable tissue was achieved. A tie-over bandage was used 
to better fix the medication for the wound of the flank. At that time wounds underwent a surgical 
sharp debridement to remove all the non-viable tissue.   
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Fig.11: C. Wounds at days 17. A healthy granulation tissue filled all the wound bed of the flank wound. 
D. The wound on the shoulder was considered healed.  
 
Fig. 11: E. Wounds at days 54. Even the wound on the flank was considered healed.  
Fig. 11: F. Four months after complete healing. An alopecic area with hyperpigmentation of the 
epidermal tissue was present.   
 
Fig. 11: G. Wound healing assessment for case 6. Wound two-axis area: blue line; BWAT assessment: 
red line; WBS assessment: green line 
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Case 8: Excisional wound after failure of a free skin graft. The dog was 
undergoing chemotherapeutic protocol with vinblastine and prednisone started 
two weeks before the surgery and continued during wound healing period.   
 
 
Fig.12 : A. Wounds at admission. A blood clot separated the free skin graft from the underlying tissue. 
B. The wound was than healed by second intention.   
 
 
Fig. 12: C. Wounds a week after admission. Granulation tissue began to form.  
Fig.12: D. Granulation tissue completely filled the wound bed.  
A B 
C  D 
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Fig.12: E. Wounds completely healed at 49 days after admission 
 
 
 
Fig. 12: F. Wound healing assessment for case 8. Wound two-axis area: blue line; BWAT assessment: 
red line; WBS assessment: green line 
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5. Discussion 
 
The roles of HA in each phase of wound healing have been investigated 
intensively in human medicine, and HA’s properties have recently been 
successfully used in a number of wound dressing.54,61-65,91-93  In veterinary 
medicine the potential for using HA-based medication on open skin wound in 
dogs was studied only by two case-control papers in which a cross-linked HA 
was applied on small (2 cm × 2 cm) experimental open wounds. In those studies 
controversial results were obtained and also taking into account the positive 
experience of human medicine, the additional investigation should be reached to 
increase the knowledge of HA properties also for companion animals.6,7 In 
addition, medical experimental research does not always replicate clinical 
conditions such as the presence of comorbidities or peripheral tissue damage 
that impair the healing process as happen instead in all non-experimental 
wounds making those results’ studies potentially no reproducible in the clinical 
setting.91 Regarding these issues, the use of HA-containing dressings was 
evaluated for the first time on a small cohort of non-experimental cutaneous 
open wounds in client-owned dogs.  
The commercial available HA formulations tested in this study were found easy 
to apply, without the need of intensive staff training and so could be used not 
only in a veterinary second opinion hospital but even in an ambulatory setting. 
The formulations in gauze, cream, granules and spray allowed to apply the 
medication also in the presence of very irregular shape and inside the 
undermined pocket. The bandages were applied as routine so dogs were able to 
stay at home and to live a regular life with the exception of takes care of 
bandages (e.g. T-shirt covering the bandage, Elizabethan collar). Owners were 
instructed to re-build the bandages only when the wounds were in the late stage 
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of progression, and no problems were recorded at the weekly examination using 
this strategy. In fact, the formulations in cream and spray were also described for 
auto-medication for human beings.  
No side effects on wounds and periwounds tissue were recorded in the present 
study. This finding is in according with the past literature in which no side effect 
and no allergic response were reported for the topical application of HA in 
wounds, both for dogs and human.6,7,61,92,93 Hadley and colleagues histologically 
proved the absence of inflammatory reaction around the HA-based gel applied 
on their experimental wounds in dogs.7 The unpleasant odor reported by some 
owners associated with the HA products used in the present study was otherwise 
tolerated and has been related to the degradation of HA associated to the 
presence of wound fluid. To bypass the uncomfortable sensation linked to the 
use of spray, owners were instructed to not use it directly on the wound but to 
drench sterile gauze and to apply it on the wound.  
The frequency between each dressing change varied widely and was mostly 
influenced by type of dressing and characteristic of the wound at assessment. 
The adsorbent medication made of partial benzyl ester derivative of hyaluronan 
was re-applied every about 4 days even if for human medicine this product could 
be leave until for a week. This medication breaks down in contact with wound 
exudate forming a gel rich of HA. The degradation timing depends on exudate 
levels and when at the assessment wound achieved a high exudate score the 
dressing change was scheduled more frequent than weekly. At the same time 
clinician had to consider this degradation and gel forming when evaluated the 
type and amount of exudate, especially when the bandage was early changed and 
the product was not totally adsorbed. It may be possible that this consideration 
has led to a more frequent dressing change in the first wounds treated respect to 
the last when a good mastery of the product was achieved. 
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One factor that should be taken into account in the choice of dressing is the 
cost-benefits ration and even, for veterinary practitioners, the easy availability 
also for not hospital facility. The HA-containing dressings used in this study are 
available in any drug store of the country and have a cost range from of about 30 
(gauze, 10 cm × 10 cm) to 10 euro (15 g cream tube) at which should be added 
the regular cost for bandage materials and clinical control. Obviously, the cost 
increases with increasing size of treated area and with the need of more than one 
product. On the contrary, the increased cost of an advance medical dressing has 
to be set against a shorter period of treatment and also to the lack of need of 
hospitalization for the type of medications used in this study. 
In front of these good results is mandatory to achieve also a good wound 
outcome. To test the outcome of a wound medication a control group is always 
necessary. The explorative intent of this study, the small number of the sample 
and the difficult to build a control group that overlaps the characteristic of non-
experimental wounds and patients allow to extrapolate only observational data. 
Authors considered the TWH (of about 1 month) achieved with HA-based 
dressing in canine non-experimental open wound a promising result. In 
particular, the wound area reduction was higher between 7 and 14 days with a 
mean wound area at 2 weeks halved than admission (Figures-4 and -5). Recently, 
the use of negative pressure in spontaneous wounds healed only by the second 
intention achieved a mean healing time of 26 days while excisional wound 
without advance dressing achieved a median healing time of 53 days.5,94  
Nevertheless due to the specific nature and features of spontaneous injuries any 
comparison with other studies that used different dressing or therapy involves 
possible high-risk bias and confirmation in further studies of the impact of the 
HA-medications on wound outcome is necessary. 
Reading the literature on HA and wound healing seemed that HA plays a role in 
each phases of the healing process. Many studies found that HA not only 
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enhance the fibroblast and vascular deposition in the granulation tissue, but also 
the keratinocyte proliferation during epithelialization.56-60 Due to ethical 
implication and the clinical nature of this study no incisional biopsy of the 
healing tissues was sample during the present study, so was impossible to better 
elucidate the structure of the newborn tissues, and in addition in absence of a 
control group to have a comparison with no treated wounds. Otherwise, to 
authors’ experience and observation the granulation tissue filled the wound gap 
in a very quick period and generally grossly appeared of a very good and healthy 
quality making supposed that the HA have principally promoted the deposition 
of fibroblast and neo-angiogenesis. This is also reported by another experimental 
study on HA in dogs, in which authors described a better gross appearance of 
the granulation tissue for the treated wounds.6 
Periodic wound assessment to document healing progression and effectiveness 
of treatment is one of the most important parts of wound management. Wounds 
were reassessed at every bandage change. In human medicine, the frequency of 
assessment is often related to specific patient and wound, with a higher 
frequency for acute than chronic wound.82 In veterinary experimental research 
with HA the wounds were re-assessed every 3 days or weekly but no information 
on clinical setting is available.6,7 In author’s experience with these HA-based 
products the assessment may be generally repeated after a period from 4 to 7 
days to detected noticeable alteration that justify to declare an improvement or 
worsening of the wound even if the clinician as to change early the dressing as 
happen in case of dogs prone to remove it. 
Wound dimensions are the most frequent used parameters for healing evaluation 
in clinical and research settings.7-9,11,80[8-10,13,27]. Many are the possible 
measures to evaluate a dimensional assessment.81 In veterinary medicine, the 
majority of the studies referred to area for measuring the wound extension. 7-9,11 
In experimental setting often digital imaging and software application have been 
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used while linear metric dimension and mathematical formula have been used in 
clinical research.7-9, 94 Obviously, the technique to calculate the wound area as a 
rectangular only approximates the real wound area that could be of irregular 
shape, but it was made because was the simplest, least expensive, reliable and 
fast method in a clinical setting.81 On the other hand, this could have 
overestimated the real size of about 25% in case of circular wound area.81 In fact, 
the two-axis methods generally represent a bigger wound area respect to 
software assessment also in this present study. However, this method was always 
applied, and the possible error was repeated during the assessments making 
probably correct the comparison of two evaluations in the same wound. To be 
more precise even the software was applied. This software was free, easy to use 
and the only necessary equipment is a digital camera and a personal computer. 
However, the authors find some possible bias use it when the extension of the 
wound followed the natural curves of the body (e.g. wound extended for more 
than 180° around extremity) and the bi-dimensional picture achieved was not 
able to represent the real extension. In these cases, the technique reported by 
Tambella et al. where the perimeter of the open wound area was captured by 
hand with a fine tip permanent marking pen on a transparent sheet placed 
directly on the wound bed and then photographed and measured with the 
software should be use.12 Taking in consideration the difference achieved with 
this two methods (Table-3) and the absence of a gold standard, the method 
chooses at the first assessment should be repeated during the healing process, at 
least until the wound became small (<9 cm2) and the difference could be more 
probably <1 cm2. 
The use of wound area alone in the assessment of wound healing progression 
has the disadvantage to do not take into account the change in the quality of the 
wound bed that not always reflect a change or a reduction in wound 
dimensions.80 In veterinary medicine no data are available concerning this kind 
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of assessment even if some authors discussed about the addition in wound 
judgment of other parameters, such as fluid characteristics, granulation tissue, 
periwound, status and hidratation to subjectively evaluated experimental wound 
in dogs.7,11,12 Considering this, two visual wound scales previously used in human 
medicine were parallel applied at each assessment. In human medicine this kind 
of evaluations were very diffuse and even if a real gold standard method is not 
approved, these tools represent an active part of wound management.80,77,95 
These scales are generally used and drawn for the evaluation of the most 
frequent human chronic wounds and their application on an acute open wound 
in dogs remained an explorative attempt. 
In addition, the weight of the different tool characterizing the wound at the 
assessment reflect the mutability of the healing process and is unequivocally 
linked to the selection of appropriate dressing that should be based on the type 
of wound, healing status, bio-burden present and amount of exudate.77,96 In this 
scenario, wound quality assessment is also performed to determine if wound is 
changing, not only because it actually may be healing, but also because changes 
provide useful tool to improve the plan of care and direct clinical decision-
making.87 In this case series the scores, in association with manufacture’s 
instruction linked to TIME approach, were used to direct decision about which 
HA-containing dressing should be apply. The TIME approach is based on the 
goal to remove local barriers to healing and optimizes the tissue environment to 
achieve wound healing. This concept of wound bed preparation in human 
medicine initially arose out of a need to address chronic wound but many 
wounds that fall into the traditional classification of “acute” could be amenable 
to management with the wound bed preparation concept.77 The TIME concept 
of human medicine, although not specifically studied in the veterinary field, 
partially overlaps wound care guidelines reported for animal and are also 
reported in animal wound care book.1,97 
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The best BWAT score for all wounds was obtained the same date of the total 
epithelialization while the best WBS score was achieved before. This result is 
justified by the fact that WBS score was delineated in human chronic wound to 
predict ultimate wound closure and not to assess the completion of the process 
as BWAT does, instead.90 After the obtainment of the best WBS score, all the 12 
wounds progressively healed until complete epithelialization. In addition using 
both scales, the greatest reduction of the score was obtained in the 1st week with 
a mean decrease of 66.3% for WBS and 33.8% for BWAT respect to the 
admission scores. These results confirmed that qualitative assessment was 
especially useful in the early aspects of the healing of the acute wound in dogs 
when often the size of the wound do not change.80 Furthermore, the wound that 
received debridement, even medical or surgical, resulted in a larger size that 
taking into account only this data could not revealed an improvement of the 
quality of the wound as instead confirmed by both scoring systems (Table-2). 
In both scales many are the parameters considered to elaborate the final score. 
In human seems that exudate control, minimal eschar and decrease size have a 
higher prognostic impact on wound healing of chronic wound respect to other 
such as quality of granulation tissue.87,98 The low number of cases in this study 
did not permit to analyze which parameters including in the scales could have 
the higher impact on second intention wound healing in acute wounds in dogs. 
The BWAT scale takes into account more parameters than the WBS and 
nowadays this could allow considering it more complete even taking into 
account the higher agreement achieved by two different operators. However, 
further studies are needed to delineate which parameters are more useful to 
describe the healing process in dogs and which are secondary or even 
unnecessary. 
  
 61 
   
CHAPTER 6 
Conclusion 
 62 
6. Conclusion 
 
The Hyaluronic Acid-containing dressings used in this study are easy to apply, 
well tolerated and carry promising results in improving healing of acute open 
wounds in dogs. In this explorative study the investigation of prognostic 
significances of site and size of the wound on healing time was not possible and 
further studies are necessary, also taking into account the comparison between 
different dressing and therapy on healing rate and on cost-benefit ratio. The use 
of scale scoring systems to assess wound healing gives consistent results 
complimentary to wound area reduction and the application of this assessment 
tools should be evaluated in veterinary medicine. The therapeutic approach 
based on quality wound assessment used in this study could be considered a 
primary pilot systemic decision-making process easy to follow wound treatment 
routine with HA-based dressing in daily veterinary clinical practice. 
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